ENANTA PHARMACEUTICALS, INC Marketable Securities, Gain (Loss)
ENANTA PHARMACEUTICALS, INC (ENTA) reported Marketable Securities, Gain (Loss) of $4.00 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-11.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2016-08-09
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for the quarter ending 2015-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for the quarter ending 2015-06-30 was $3.00K.
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for the quarter ending 2015-03-31 was $0.00.
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for the quarter ending 2014-12-31 was $1.00K.
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for fiscal 2015 was $4.00K, a 33.33% increase from fiscal 2014.
- ENANTA PHARMACEUTICALS, INC marketable securities, gain (loss) for fiscal 2014 was $3.00K.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 9 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $3.00K derived: sum of 2 quarters · filed 2016-08-09 | $3.00K derived: sum of 3 quarters · filed 2016-08-09 | $4.00K 10-K · filed 2015-12-11 |
| 2015-06-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $3.00K derived: sum of 2 quarters · filed 2016-08-09 | $4.00K 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $1.00K 10-Q · filed 2016-05-10 | ||
| 2014-12-31 | $1.00K 10-Q · filed 2016-02-09 | |||
| 2014-09-30 | $3.00K 10-K · filed 2015-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |